Chondroitin Sulfate as a Key Molecule in the Development of Atherosclerosis and Cancer Progression

Advances in Pharmacology

Volumn 53, Issue , 2006, Pages 281-295

  Theocharis, A D ^a,c   Tsolakis, I ^b,c   Tzanakakis, G N ^b,c   Karamanos, Nikos K ^a,c  

^a UNIVERSITY OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHONDROITIN SULFATE; CYTOKINE; EPIDERMAL GROWTH FACTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HEPARIN-BINDING EGF-LIKE GROWTH FACTOR; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEOCHONDROITIN SULFATE; UNCLASSIFIED DRUG; VERSICAN;

ANIMAL; AORTA; ATHEROSCLEROSIS; BIOMECHANICS; CHEMISTRY; DISEASE COURSE; EXTRACELLULAR MATRIX; HUMAN; METABOLISM; NEOPLASM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; AORTA; ATHEROSCLEROSIS; BIOMECHANICS; CHONDROITIN SULFATES; CYTOKINES; DISEASE PROGRESSION; EPIDERMAL GROWTH FACTOR; EXTRACELLULAR MATRIX; HUMANS; LIPOPROTEINS, LDL; NEOPLASMS; PROTEOCHONDROITIN SULFATES; SIGNAL TRANSDUCTION; VERSICANS;

EID: 33846137005     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(05)53013-8     Document Type: Review

References (44)

1. 2+ mediated LDL oxidation. FEBS Lett. 403 (1997) 154-158
2. Boren J., Olin K., Lee I., Chait A., Wight T.N., and Innerarity T.L. Identification of a principal proteoglycan binding site in LDL: A single point mutation in apoB-100 severely affects proteoglycan interaction without affecting LDL receptor binding. J. Clin. Invest. 101 (1998) 2658-2664
3. Brooke B.S., Karnik S.K., and Li D.Y. Extracellular matrix in vascular morphogenesis and disease: Structure versus signal. Trends Cell Biol. 13 (2003) 51-56
4. Camejo G., Hurt-Camejo E., Wiklund O., and Bondjers G. Association of apoB-lipoproteins with arterial proteoglycans: Pathological significance and molecular basis. Atherosclerosis 139 (1998) 205-222
5. Cardoso L.E., and Mourao P.A. Glycosaminoglycan fraction from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL. Arterioscler. Thromb. 14 (1994) 115-124
6. Deepa S.S., Umehara Y., Higashiyama S., Itoh N., and Sugahara K. Specific interactions of oversulfated chondroitin sulphate E with various heparin-binding growth factors: Implications as a physiological binding partner. J. Biol. Chem. 277 (2002) 43707-43716
7. Flood C., Gustafsson M., Richardson P.E., Harvey S.C., Segrest J.P., and Boren J. Identification of the proteoglycan binding site in apolipoprotein B48. J. Biol. Chem. 277 (2002) 32228-32233
8. Hinek A., Mecham R.P., Keeley F., and Rabinovitch M. Impaired elastin fiber assembly related to reduced 67-kD elastin-binding protein in fetal lamb ductus arteriosus and in cultured aortic smooth muscle cells treated with chondroitin sulfate. J. Clin. Invest. 88 (1991) 2083-2094
9. Hinek A., Braun K.R., Liu K., Wang Y., and Wight T.N. Retrovirally mediated overexpression of versican V3 reverses impaired elastogenesis and heightened proliferation exhibited by fibroblasts from Costello syndrome and Hurler disease patients. Am. J. Pathol. 164 (2004) 119-131
10. Hirose J., Kawashima H., Yoshie O., Tashiro K., and Miyasaka M. Versican interacts with chemokines and modulates cellular responces. J. Biol. Chem. 276 (2001) 5228-5234
11. Hurt-Camejo E., Rosengren B., Sartipy P., Elfsberg K., Camejo G., and Svensson L. CD44, a cell surface chondroitin sulfate proteoglycan, mediates binding of interferon-γ and some of its biological effects on human vascular smooth muscle cells. J. Biol. Chem. 274 (1999) 18957-18964
12. Iozzo R.V. Matrix proteoglycans: From molecular design to cellular function. Annu. Rev. Biochem. 67 (1998) 609-652
13. Kadomatsu K., and Muramatsu T. Midkine and pleiotrophin in neural development and cancer. Cancer Lett. 204 (2004) 127-143
14. Kawashima H., Li Y.F., Watanabe N., Hirose J., Hirose M., and Miyasaka M. Identification and characterization of ligands for L-selectin in the kidney: Versican, a large chondroitin sulfate proteoglycan, is a ligand for L-selectin. Int. Immunol. 11 (1999) 393-405
15. Kawashima H., Hirose M., Hirose J., Nagakubo D., Plaas A., and Miyasaka M. Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44. J. Biol. Chem. 275 (2000) 35448-35456
16. Kawashima H., Atarashi K., Hirose M., Hirose J., Yamada S., Sugahara K., and Miyasaka M. Oversulfated chondroitin/dermatan sulfates containing GlcAβ1/IdoAa1-3GalNAc(4,6-O-disulfate) interact with L- and P-selectin and chemokines. J. Biol. Chem. 277 (2002) 12921-12930
17. Kjellen L., and Lindahl U. Proteoglycans: Structures and interactions. Annu. Rev. Biochem. 60 (1991) 443-475
18. Lee C.M., Tanaka T., Murai T., Kondo M., Kimura J., Su W., Kitagawa T., Ito T., Matsuda H., and Miyasaka M. Novel chondroitin sulphate-binding cationic liposomes loaded with cisplatin efficiently suppress the local growth and liver metastasis of tumor cells in vivo. Cancer Res. 62 (2002) 4282-4288
19. Lemire J.M., Merrilees M.J., Braun K.R., and Wight T.N. Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro. J. Cell. Physiol. 190 (2002) 38-45
20. Llorente-Cortes V., Otero-Vinas M., Hurt-Camejo E., Martinez-Gonzalez J., and Badimon L. Human coronary smooth muscle cells internalize versican-modified LDL through LDL receptor-related protein and LDL receptors. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 387-393
21. Merle B., Durussel L., Delmas P.D., and Clezardin P. Decorin inhibits cell migration through a process requiring its glycosaminoglycan side chain. J. Cell. Biochem. 75 (1999) 538-546
22. Merrilees M.J., Lemire J.M., Fischer J.W., Kinsella M.G., Braun K.R., Clowes A.W., and Wight T.N. Retrovirally mediated overexpression of versican V3 by arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointima after vascular injury. Circ. Res. 90 (2002) 481-487
23. Pentikainen M.O., Oorni K., Lassila R., and Kovanen P.T. The proteoglycan decorin links low density lipoproteins with collagen type I. J. Biol. Chem. 272 (1997) 7633-7638
24. Perissinotto D., Iacopetti P., Bellina I., Doliana R., Colombatti A., Pettway Z., Bronner-Fraser M., Shinomura T., Kimata K., Morgelin M., Lofberg J., and Perris R. Avian neural crest cell migration is diversely regulated by the two major hyaluronan-binding proteoglycans PG-M/versican and aggrecan. Development 127 (2000) 2823-2842
25. Polykratis A., Katsoris P., Courty J., and Papadimitriou E. Characterization of heparin affin regulatory peptide signalling in human endothelial cells. J. Biol. Chem. 280 (2005) 22454-22461
26. Pumphrey C.Y., Theus A.M., Li S., Parrish R.S., and Sanderson R.D. Neoglycans, carbodiimide-modified glycosaminoglycans: A new class of anticancer agents that inhibit cancer cell proliferation and induce apoptosis. Cancer Res. 62 (2002) 3722-3728
27. Sambandam T., Baker J.R., Christner J.E., and Ekborg S.L. Specificity of the low density lipoprotein-glycosaminoglycan interaction. Arterioscler. Thromb. 11 (1991) 561-568
28. Skandalis S.S., Theocharis A.D., Theocharis D.A., Papadas T., Vynios D.H., and Papageorgakopoulou N. Matrix proteoglycans are markedly affected in advanced laryngeal squamous cell carcinoma. Biochim. Biophys. Acta 1689 (2004) 152-161
29. Sugahara K., Mikami T., Uyama T., Mizuguchi S., Nomura K., and Kitagawa H. Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate. Curr. Opin. Struct. Biol. 13 (2003) 612-620
30. Theocharis A.D. Human colon adenocarcinoma is associated with specific post-translational modifications of versican and decorin. Biochim. Biophys. Acta 1588 (2002) 165-172
31. Theocharis A.D., and Karamanos N.K. Decreased biglycan expression and differential decorin localization in human abdominal aortic aneurysms. Atherosclerosis 165 (2002) 221-230
32. Theocharis A.D., and Theoharis D.A. High-performance capillary electrophoretic analysis of hyaluronan and galactosaminoglycan-disaccharides in gastrointestinal carcinomas. Differential disaccharide composition as a possible tool-indicator for malignancies. Biomed. Chromatogr. 16 (2002) 157-161
33. Theocharis A.D., Tsolakis I., Tsegenidis T., and Karamanos N.K. Human abdominal aortic aneurysm is closely associated with compositional and specific structural modifications at the glycosaminoglycan level. Atherosclerosis 145 (1999) 359-368
34. Theocharis A.D., Tsara M.E., Papageorgacopoulou N., Karavias D.D., and Theocharis D.A. Pancreatic carcinoma is characterized by elevated content of hyaluronan and chondroitin sulfate with altered disaccharide composition. Biochim. Biophys. Acta 1502 (2000) 201-206
35. Theocharis A.D., Tsolakis I., Hjerpe A., and Karamanos N.K. Human abdominal aortic aneurysm is characterized by decreased versican concentration and specific downregulation of versican isoform V0. Atherosclerosis 154 (2001) 367-376
36. Theocharis A.D., Theocharis D.A., DeLuca G., Hjerpe A., and Karamanos N.K. Compositional and structural alterations of chondroitin and dermatan sulfates during the progression of atherosclerosis and aneurysmal dilatation of the human abdominal aorta. Biochimie 84 (2002) 667-674
37. Theocharis A.D., Vynios D.H., Papageorgakopoulou N., Skandalis S.S., and Theocharis D.A. Altered content, composition and structure of glycosaminoglycans and proteoglycans in gastric carcinoma. Int. J. Biochem. Cell Biol. 35 (2003) 376-390
38. Timar J., Lapis K., Dudas J., Sebestyen A., Kopper L., and Kovalszky I. Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer. Semin. Cancer Biol. 12 (2002) 173-186
39. Tsara M.E., Theocharis A.D., and Theocharis D.A. Compositional and structural alterations of proteoglycans in human rectum carcinoma with special reference to versican and decorin. Anticancer Res. 22 (2002) 2893-2898
40. Wegrowski Y., and Maquart F.X. Involvement of stromal proteoglycans in tumour progression. Crit. Rev. Oncol. Hematol. 49 (2004) 259-268
41. Wight T.N. Versican: A versatile extracellular matrix proteoglycan in cell biology. Curr. Opin. Cell Biol. 14 (2002) 617-623
42. Wight T.N., and Merrilees M.J. Proteoglycans in atherosclerosis and restenosis: Key roles for versican. Circ. Res. 94 (2004) 1158-1167
43. Wight T.N., Kinsella M.G., and Owarnstrom E.E. The role of proteoglycans in cell adhesion, migration and proliferation. Curr. Opin. Cell Biol. 4 (1992) 793-801
44. Yamaguchi Y., Mann D.M., and Ruoslahti E. Negative regulator of transforming growth factor-β by the proteoglycan decorin. Nature 346 (1990) 281-284